FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

AMRUTANJAN Share Price Discussion

Amrutanjan Health Care Ltd.
NSE: AMRUTANJAN | BSE: 590006 | ISIN: INE098F01031 | Sector: Pharmaceuticals and health care

AMRUTANJAN Rating

0/5 (0 Ratings)
AMRUTANJAN Share Price *
506.4 +19.2 (3.94%)
* (quote may be delayed)
Find answers to all your questions on live AMRUTANJAN message board: Is AMRUTANJAN buy or sell? Should I buy AMRUTANJAN shares? Why are AMRUTANJAN shares falling? Should I invest in AMRUTANJAN stock?

You can also check AMRUTANJAN share price target recommended by brokerages.

AMRUTANJAN Discussion Forum


12-Feb-2020 03:18:03 PM - INDIA'S AMRUTANJAN HEALTH CARE LTD AJAN.NS DEC-QTR PROFIT 94.9 MLN RUPEES VS 52.9 MLN RUPEES YR AGO
12-Feb-2020 03:18:18 PM - AMRUTANJAN HEALTH CARE LTD AJAN.NS DEC-QTR REVENUE FROM OPS 827.5 MLN RUPEES VS 699.4 MLN RUPEES YR AGO
12-Feb-2020 03:18:54 PM ...
Read more...
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 TO 494

AMRUTANJAN...HIGH 522
Like
reply
Reply
@umanath • Reputation: 563

AMRUTANJAN - 430363

Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 TO 468

AMRUTANJAN...304 TO 494
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 454+

AMRUTANJAN...304 TO 468
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 440+ ACHV TARGET...304 TO 440...

AMRUTANJAN...HIGH 454+
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 325 HOLD ON FOR 435

AMRUTANJAN...HIGH 440+
ACHV TARGET...304 TO 440+
BK FULL OR HOLD ONLY FREE
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 BUY RANGE...300/280 PUT 276 AS...

AMRUTANJAN...304 TO 430
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 325 HOLD ON FOR 435

AMRUTANJAN...HIGH 417+
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 BUY RANGE...300/280 PUT 276 AS...

AMRUTANJAN...HIGH 381
Like
reply
Reply
@100billionclub • Reputation: 3,450

CASH: BUY AMRUTANJAN ABV 348
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 BUY RANGE...300/280 PUT 276 AS...

AMRUTANJAN...HIGH 352+
BK FULL & MV INVESTMENT IN PPAP AUTO 4 TARGET 220/225+
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 325 HOLD ON FOR 435

AMRUTANJAN...HIGH 342
Like
reply
Reply
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...HIGH 315

AMRUTANJAN...HIGH 325
HOLD ON FOR 435
Like
reply
Reply

Buy amrutanjanta 321 target 350
Like
reply
Reply (1)
Latest replies
Sanjay Gupta @sanjaygupta
Sep 17 7:10 PM

SL for this call 311now ?
HALAL INVESTMENT in AMRUTANJAN
AMRUTANJAN...304 BUY RANGE...300/280 PUT 276 AS...

AMRUTANJAN...HIGH 315
Like
reply
Reply

AMRUTANJAN...304
BUY RANGE...300/280
PUT 276 AS CBSL
EXPECT TARGET 325/335+
Like
reply
Reply (1)
Latest replies
TAPAS GHOSH @tapasghosh
Sep 9 5:17 PM

sir ZYDUS 1840
  • AMRUTANJAN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization907.39
    Enterprise Value826.08
    Price to Earnings39.32
    Price to Book Value6.23
    Return on Capital Employed0.26
    Return on Equity0.16
    Face Value1
    Dividend Yield0.01
  • AMRUTANJAN Share Price - Technicals

    keyboard_arrow_down
    AMRUTANJAN - 52 Week High₹555
    AMRUTANJAN - 52 Week Low₹274.35
  • AMRUTANJAN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 19491.05524.75491.05506.4
    Feb 18500.95500.95480.55487.2
    Feb 17509.9519495500.2
    Feb 14501519.5500505.55
    Feb 13552.5555501.15506.65
  • AMRUTANJAN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹476.6
    30 Day Moving Average₹474.35
    50 Day Moving Average₹459.17
    100 Day Moving Average₹439.47
    200 Day Moving Average₹370.01
  • AMRUTANJAN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue223.17222.030.01
    Operating Profit28.530.63-0.07
    Profit Before Tax32.8833.13-0.01
    Net Income19.9721.41-0.07
  • AMRUTANJAN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds145.73128.660.13
    Total Liabilities41.8838.720.08
    Total Assets187.61167.380.12
  • AMRUTANJAN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5.5112.8-0.57
    Cash from Investing Activity7.9-9.36-1.84
    Cash from Financing Activity-9.47-4.531.09
    Net Cash Flow3.94-1.1-4.58
  • AMRUTANJAN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.120.13
    Return on Equity0.160.17
    Return on Capital Employed0.260.26
  • AMRUTANJAN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.37
    3 Year CAGR Growth in Operating Profit0.15
    3 Year CAGR Growth in EBIDTA0.23
    3 Year CAGR Growth in Net Income0.16
    3 Yr CAGR Growth - Diluted EPS0.15
  • AMRUTANJAN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.65
    5 Year CAGR Growth in Operating Profit0.48
    5 Year CAGR Growth in EBIDTA0.54
    5 Year CAGR Growth in Net Income0.65
    3 Yr CAGR Growth - Diluted EPS0.65
  • AMRUTANJAN - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.